Free Report Schweiger V, et al
26 Despite this trend, conventional treatments for CNS disorders have predominantly relied on administration routes that target peripheral areas, such as oral and parenteral methods
It was the first paper to show the therapeutic potential of GLP-1 (7-37) for treatment of type 2 diabetes (Nathan, Schreiber, Fogel
Stoyanovsky DA, Jiang J, Murphy MP et al (2014) Design and synthesis of a mitochondria-targeted mimic of glutathione peroxidase, mitoebselen-2, as a radiation mitigator
More specific indicators include numbness or tingling in hands and feet, pale or yellowish skin tone, mouth soreness, or difficulty with balance and coordination
In separate-vial workflows, plan vial sizes around the TB-500 use rate